Levofloxacin
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Overview
Levofloxacin is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Levofloxacin clinical trials
Explore related
Medical disclaimer. This page summarizes research about Levofloxacin for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.